Franklin M. Berger

Companies

• Atea Pharmaceuticals, Inc.Board member Oct 29, 2020 to now¹
• Essa Pharma (United States)Board member Oct 1, 2020 to now²
• Kezar Life Sciences, Inc.Board member Jun 20, 2018 to now³
• Rain Oncology Inc.Board member Apr 22, 2021 to Jan 26, 2024⁴
• Atreca, Inc.Board member Jun 19, 2019 to Jun 15, 2023⁵
• Proteostasis Therapeutics (United States)Board member Feb 10, 2016 to Jul 1, 2020⁶
• Forte Biosciences, Inc.Board member Apr 12, 2017 to Oct 4, 2019⁷
• SeagenBoard member May 19, 2006 to Feb 25, 2014⁸
• Lineage Cell TherapeuticsBoard member May 23, 2013 to Aug 22, 2013⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAtea Pharmaceuticals, Inc. AVIR536,097 shares¹⁰$2.3M at $4.31Jun 18, 2026
• EPEssa Pharma (United States)0 shares¹¹Oct 9, 2025
• KLKezar Life Sciences, Inc.0 shares¹²May 11, 2026
• RORain Oncology Inc.0 shares¹³Jan 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Exercised options 29,600 shares of Atea Pharmaceuticals, Inc.¹⁰
• May 11, 2026U 89,069 shares of Kezar Life Sciences, Inc.¹²
• Oct 9, 2025Returned to company 784,404 shares of Essa Pharma (United States)¹¹
• Jun 20, 2025Exercised options 29,600 shares of Atea Pharmaceuticals, Inc.¹⁴
• Jan 16, 2025Bought 10,000 shares at $3.36 of Atea Pharmaceuticals, Inc.¹⁵
• Jan 16, 2025Bought 10,000 shares at $3.36 of Atea Pharmaceuticals, Inc.¹⁶
• Jan 15, 2025Bought 15,000 shares at $3.19 of Atea Pharmaceuticals, Inc.¹⁵
• Jan 15, 2025Bought 15,000 shares at $3.19 of Atea Pharmaceuticals, Inc.¹⁶
• Dec 10, 2024Sold 359,606 shares at $2.85 of Atea Pharmaceuticals, Inc.¹⁷
• Jun 16, 2024Exercised options 33,150 shares of Atea Pharmaceuticals, Inc.¹⁸
• Jan 26, 2024U 1,005,207 shares of Rain Oncology Inc.¹³
• Nov 21, 2023Bought 23,259 shares at $5.73 of Essa Pharma (United States)¹⁹
• Nov 3, 2023Bought 16,471 shares at $5.99 of Essa Pharma (United States)²⁰
• Nov 2, 2023Bought 60,000 shares at $5.35 of Essa Pharma (United States)²⁰
• Dec 21, 2022Sold 34,334 shares at $2.42 of Essa Pharma (United States)²¹
• Dec 21, 2022Sold 37,889 shares at $2.41 of Essa Pharma (United States)²¹
• Dec 20, 2022Sold 43,617 shares at $2.53 of Essa Pharma (United States)²¹
• Dec 16, 2022Sold 50,000 shares at $2.67 of Essa Pharma (United States)²¹
• Dec 15, 2022Sold 50,000 shares at $2.86 of Essa Pharma (United States)²¹
• Dec 15, 2022Sold 32,000 shares at $2.90 of Essa Pharma (United States)²¹
• Dec 14, 2022Sold 25,000 shares at $3.00 of Essa Pharma (United States)²¹
• Nov 22, 2022Bought 77,000 shares at $8.27 of Rain Oncology Inc.²²
• Nov 21, 2022Bought 45,000 shares at $7.80 of Rain Oncology Inc.²²
• Nov 14, 2022Sold 16,166 shares at $5.16 of Atea Pharmaceuticals, Inc.²³
• Nov 11, 2022Sold 25,500 shares at $5.15 of Atea Pharmaceuticals, Inc.²³